Argon Plasma Coagulation: Elucidation of the Mechanism of Gas Embolism

Respiration ◽  
2021 ◽  
pp. 1-5
Author(s):  
Erik E. Folch ◽  
Catherine L. Oberg ◽  
Atul C. Mehta ◽  
Adnan Majid ◽  
Colleen Keyes ◽  
...  

<b><i>Background:</i></b> Argon plasma coagulation (APC) is a tool used in the management of tracheobronchial obstruction or bleeding. Complications include gas embolism which can cause devastating effects including hemodynamic instability, cardiac arrest, and stroke. Multiple theories as to how gas embolism occurs with APC have been postulated; however, none have identified the exact mechanism. <b><i>Objectives:</i></b> To identify the mechanism by which APC causes gas embolism in the tracheobronchial tree. <b><i>Methods:</i></b> Using an explanted porcine tracheobronchial tree with lung parenchyma, the APC catheter was applied through noncontact and direct contact to the endobronchial airway mucosa via flexible bronchoscopy. This was done at multiple gas flow settings and pulse durations. Visual changes in the mucosa were photographed, videoed, and described. <b><i>Results:</i></b> Gross evidence of submucosal gas transfer occurred when the APC catheter was in direct contact with the mucosa at all gas flow settings in all applications, despite using shorter pulse durations. Whenever the catheter was not in contact with the mucosa, there was no transfer of gas at any gas flow setting or pulse duration. <b><i>Conclusions:</i></b> Direct mucosal contact with the APC probe leads to submucosal gas deposition and is a likely mechanism for gas entry into the intravascular space. In reported cases of APC-associated gas embolism, presence of a vascularized endobronchial tumor may have increased the risk of gas tracking into the intravascular space. Care should be taken when applying APC during brisk bleeding or limited vision, as inadvertent mucosal contact may occur and could increase the risk of gas embolism.

CHEST Journal ◽  
2010 ◽  
Vol 138 (4) ◽  
pp. 116A
Author(s):  
Samaan Rafeq ◽  
Sugantha Sundar ◽  
Armin Ernst ◽  
Adnan Majid

Respiration ◽  
2012 ◽  
Vol 83 (3) ◽  
pp. 267-270 ◽  
Author(s):  
Yasmeen Shaw ◽  
Ken Y. Yoneda ◽  
Andrew L. Chan

2015 ◽  
Vol 100 (5) ◽  
pp. 927-929 ◽  
Author(s):  
Assaad Kesrouani ◽  
Georges Dabar ◽  
Samir Rahal ◽  
Claude Ghorra

Mucoepidermoid carcinoma of the tracheobronchial tree is a rare airway tumor (&lt;1% of all lung tumors). In adults, the majority of primary tracheal tumors are malignant. Management during pregnancy is complex and requires weighing maternal and fetal prognosis. Reported cases describe surgical resection following cesarean section. We report the first case to be treated by Argon-Plasma Coagulation (APC) in pregnancy. A 35-year-old Caucasian woman G1P0, at 27 weeks of gestation was admitted to the emergency department because of hemoptysis and severe dyspnea. Bronchoscopy and biopsies diagnosed primary tracheal mucoepidermoid carcinoma. Following an episode of tracheal bleeding, she was intubated. After thorough explanations to the family and obtaining informed consent, therapeutic bronchoscopy, under general anesthesia using a rigid bronchoscope, was performed. The tumor was cored out with the tip of the bronchoscope and removed with an alligator forceps. The tumor bed was coagulated with APC. The obstetrical team was ready to intervene in case of maternal emergency. Immediate follow-up was good, and she left the hospital 4 days later. She delivered at 39 weeks of gestation by cesarean section because of dystocia. Five years later, the patient is doing well without any signs or symptoms of recurrence. Pediatric follow-up is normal. Argon Plasma Coagulation for treatment of mucoepidermoid tracheal carcinoma is feasible during pregnancy. Reporting this case could lead to less aggressive management of mucoepidermoid carcinoma in pregnant patients.


2018 ◽  
Vol 2018 ◽  
pp. 1-14 ◽  
Author(s):  
Yanan Peng ◽  
Haizhou Wang ◽  
Juerong Feng ◽  
Shilin Fang ◽  
Meng Zhang ◽  
...  

Hemorrhagic chronic radiation proctopathy (CRP) is a common complication after pelvic radiotherapy in patients with prostate or gynecological cancers. This systematic review was conducted to evaluate the efficacy and safety of argon plasma coagulation (APC) in treating hemorrhagic CRP. The databases of PubMed, Embase, and Cochrane Library were searched for related studies from inception to July 2017. Finally, 33 studies were identified with a total of 821 hemorrhagic CRP patients. After APC treatment, hemoglobin levels increased from 7.7–13.4 g/L to 11–14 g/L (including 15 studies). All (n=33) studies reported an effective rate in rectal bleeding, among which five studies had a rate of 100%. Short-term complications were reported in 31 studies, while long-term complications in 33 studies and no complication in 11 studies. As for the severe complications, perforation was reported by 2 out of 33 studies, and the incidences were 3.3% (1/30) and 3.7% (1/27), respectively. As for APC setting, argon gas flow rate (median 1.5 L/min) and electric power (median 50 W) had no significant influence on complications and hemostasis. In conclusion, current literature indicated that APC therapy was an effective and safe strategy for hemorrhagic CRP, and large-scale prospective studies are needed to warrant our study.


CHEST Journal ◽  
2009 ◽  
Vol 136 (4) ◽  
pp. 39S
Author(s):  
Dilip Nataraj ◽  
Adnan Majid ◽  
Feroze Mahmood ◽  
Saleh Alazemi ◽  
David M. Berkowitz ◽  
...  

2007 ◽  
Vol 14 (1) ◽  
pp. 33-35 ◽  
Author(s):  
Yaron Goldman ◽  
Peter J. Panzica ◽  
Duane S. Pinto ◽  
Ralph Delatorre ◽  
David Feller-Kopman ◽  
...  

CHEST Journal ◽  
2008 ◽  
Vol 134 (5) ◽  
pp. 1066-1069 ◽  
Author(s):  
Chakravarthy Reddy ◽  
Adnan Majid ◽  
Gaetane Michaud ◽  
David Feller-Kopman ◽  
Ralph Eberhardt ◽  
...  

VASA ◽  
2008 ◽  
Vol 37 (3) ◽  
pp. 289-292 ◽  
Author(s):  
Katsinelos ◽  
Chatzimavroudis ◽  
Katsinelos ◽  
Panagiotopoulou ◽  
Kotakidou ◽  
...  

Gastric antral vascular ectasia (GAVE) is an overt or occult source of gastrointestinal bleeding. Despite several therapeutic approaches have been successfully tested for preventing chronic bleeding, some patients present recurrence of GAVE lesions. To the best of our knowledge, we report the first case, of a 86-year-old woman who presented severe iron-deficiency anemia due to GAVE and showed recurrence of GAVE lesion despite the intensive argon plasma coagulation treatment. We performed endoscopic mucosal resection of bleeding GAVE with resolution of anemia.


2015 ◽  
Vol 28 (01) ◽  
Author(s):  
A Genthner ◽  
A Eickhoff ◽  
J Albert ◽  
MD Enderle ◽  
W Linzenbold

Sign in / Sign up

Export Citation Format

Share Document